Tag: Obesity

Cells in the body remember obesity. Here’s what that means for weight loss

Consider becoming a subscriber today. Scientific American is a vital resource for anyone who values evidence-based, fact-checked journalism.

Obesity increases risk of severe infections, study finds

Obesity has long been associated with chronic illnesses such as heart disease and diabetes. However, a new study

Hims & Hers won’t sell compounded version of Novo’s obesity pill

Hims & Hers made a controversial decision to stop selling a compounded version of Novo Nordisk’s obesity pill

Unusual oral microbiome signature linked to obesity

Oral bacteria (blue) on human cheek cells (yellow) shown in a scanning electron micrographSTEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY Obesity

Weight regain seems to occur within 2 years of stopping obesity drugs

Obesity is a prevalent health issue that affects millions of people worldwide. In the quest to combat obesity,

Why the weight, and heart risks, return after stopping GLP-1 drugsStopping obesity drugs means people regain weight and lose heart health benefits 

Elizabeth Cooney, a cardiovascular disease reporter at STAT, delves into the complex world of weight loss drugs and

Employers drop obesity drug coverage as cash-pay programs grow

HCA Healthcare, one of the largest hospital systems in the United States, recently made the decision to stop

World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know

Obesity is a global epidemic that affects over a billion people worldwide, leading to serious health conditions such

There’s a Surprising Link Between a Key Nutrient, Obesity, And Alzheimer’s Risk : ScienceAlert

Obesity and Low Choline Levels Linked to Accelerated Brain Aging, Study Finds A recent study has shed light

Trump’s Price Cuts For Obesity Drugs Raise More Questions Than Answers

President Trump recently announced that his administration has successfully negotiated lower prices for certain weight loss medications with

Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly

Novo Nordisk, a leading pharmaceutical company known for its Wegovy obesity drug, has recently faced challenges in the

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Merger Agreement In a recent development, Pfizer has taken